The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis
Authors:
- 23 June 1999
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 284 (1) , 81-88
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The variation of serum lipoprotein (a) level with disease activity in psoriasisBritish Journal of Dermatology, 1998
- Clinical significance of antibodies against oxidised low density lipoprotein in early RA.Annals of the Rheumatic Diseases, 1996
- Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Antibody against oxidized low-density lipoprotein predicting myocardial infarctionArchives of internal medicine (1960), 1994
- Atherosclerosis and AutoimmunityClinical Immunology and Immunopathology, 1994
- Serum lipid and apolipoprotein levels in patients with psoriasisBritish Journal of Dermatology, 1994
- Free and complexed anti-lipoprotein antibodies in vascular diseasesAtherosclerosis, 1983
- Psoriasis and occlusive vascular diseaseBritish Journal of Dermatology, 1978
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978
- Serum Uric Acid Levels in Untreated and PUVA-Treated Patients with PsoriasisDermatology, 1978